Home | Member Login | Join/Renew | Jobs | Contact
Obesity may diminish survival in women with CLL who undergo chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab (FCR), a study from Germany found.
Read more.
563 Carter Court, Suite B, Kimberly, WI 54136920-560-5620 / 800-545-0636920-882-3655 (fax)Email: APAOG@badgerbay.co
Quick Links
About APAOGContact UsJoin as a Member